Kiri Industries Ltd
Kiri Industries Limited (KIL) is engaged in the business of manufacturing and exporting a wide range of Dyes, Dye Intermediates, and Basic Chemicals from India. [1]
- Market Cap ₹ 3,247 Cr.
- Current Price ₹ 542
- High / Low ₹ 753 / 387
- Stock P/E 244
- Book Value ₹ 131
- Dividend Yield 0.00 %
- ROCE 2.45 %
- ROE 0.78 %
- Face Value ₹ 10.0
Pros
- Promoter holding has increased by 5.00% over last quarter.
Cons
- Stock is trading at 4.14 times its book value
- The company has delivered a poor sales growth of -7.52% over past five years.
- Company has a low return on equity of -14.3% over last 3 years.
- Contingent liabilities of Rs.1,494 Cr.
- Promoters have pledged or encumbered 62.8% of their holding.
- Earnings include an other income of Rs.126 Cr.
- Debtor days have increased from 43.9 to 53.1 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Dyes And Pigments
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 583 | 780 | 889 | 965 | 884 | 1,062 | 969 | 689 | 1,137 | 601 | 633 | 656 | 718 | |
| 522 | 712 | 806 | 837 | 754 | 905 | 873 | 690 | 1,105 | 711 | 697 | 699 | 786 | |
| Operating Profit | 61 | 69 | 83 | 128 | 130 | 156 | 96 | -1 | 31 | -109 | -63 | -44 | -68 |
| OPM % | 11% | 9% | 9% | 13% | 15% | 15% | 10% | -0% | 3% | -18% | -10% | -7% | -10% |
| -28 | 2 | 12 | 2 | 3 | 3 | 4 | 2 | 2 | 23 | 37 | 105 | 126 | |
| Interest | 77 | 84 | 67 | 8 | 2 | 4 | 5 | 4 | 5 | 6 | 22 | 17 | 4 |
| Depreciation | 34 | 20 | 20 | 22 | 25 | 28 | 37 | 39 | 44 | 44 | 44 | 44 | 46 |
| Profit before tax | -78 | -34 | 7 | 99 | 107 | 126 | 59 | -42 | -15 | -136 | -93 | 1 | 8 |
| Tax % | -0% | 9% | -22% | 5% | 4% | 5% | 15% | -12% | -38% | -1% | 0% | -691% | |
| -77 | -37 | 9 | 94 | 103 | 120 | 50 | -37 | -9 | -134 | -94 | 4 | 13 | |
| EPS in Rs | -40.73 | -16.22 | 3.42 | 33.84 | 33.90 | 38.30 | 14.93 | -10.87 | -1.80 | -25.89 | -18.05 | 0.79 | 2.66 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 5% | 3% | -5% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -8% |
| 3 Years: | -17% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -39% |
| 3 Years: | 35% |
| TTM: | 116% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| 1 Year: | 23% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -9% |
| 3 Years: | -14% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 19 | 23 | 27 | 28 | 30 | 31 | 34 | 34 | 52 | 52 | 52 | 56 | 60 |
| Reserves | 95 | 139 | 148 | 366 | 481 | 597 | 636 | 597 | 573 | 439 | 345 | 665 | 726 |
| 769 | 775 | 416 | 175 | 172 | 167 | 153 | 152 | 96 | 49 | 122 | 148 | 118 | |
| 163 | 232 | 190 | 206 | 177 | 269 | 265 | 310 | 336 | 430 | 435 | 240 | 279 | |
| Total Liabilities | 1,045 | 1,169 | 780 | 775 | 860 | 1,064 | 1,088 | 1,093 | 1,057 | 970 | 954 | 1,109 | 1,183 |
| 263 | 307 | 277 | 305 | 349 | 429 | 464 | 519 | 506 | 474 | 437 | 472 | 463 | |
| CWIP | 109 | 89 | 3 | 36 | 32 | 38 | 77 | 58 | 59 | 67 | 68 | 62 | 61 |
| Investments | 170 | 172 | 174 | 168 | 168 | 140 | 140 | 140 | 140 | 140 | 142 | 163 | 157 |
| 503 | 602 | 326 | 265 | 311 | 457 | 407 | 376 | 351 | 289 | 307 | 412 | 503 | |
| Total Assets | 1,045 | 1,169 | 780 | 775 | 860 | 1,064 | 1,088 | 1,093 | 1,057 | 970 | 954 | 1,109 | 1,183 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 | -90 | 204 | 202 | 55 | 107 | 125 | 74 | 81 | 50 | -77 | -339 | |
| -35 | -44 | -40 | -86 | -63 | -90 | -102 | -69 | -24 | 3 | 27 | 12 | |
| -119 | 128 | -163 | -114 | 10 | -13 | -26 | -7 | -57 | -56 | 50 | 329 | |
| Net Cash Flow | 3 | -6 | 1 | 2 | 2 | 4 | -4 | -2 | 0 | -4 | 0 | 3 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 200 | 206 | 89 | 53 | 75 | 72 | 71 | 77 | 33 | 39 | 39 | 53 |
| Inventory Days | 76 | 34 | 28 | 22 | 38 | 58 | 58 | 86 | 52 | 77 | 92 | 128 |
| Days Payable | 47 | 56 | 75 | 79 | 77 | 86 | 108 | 166 | 118 | 274 | 267 | 153 |
| Cash Conversion Cycle | 229 | 185 | 42 | -4 | 36 | 44 | 21 | -4 | -32 | -158 | -136 | 28 |
| Working Capital Days | 37 | 156 | 2 | 20 | 52 | 32 | 5 | -37 | -51 | -142 | -180 | 27 |
| ROCE % | 3% | 6% | 9% | 19% | 17% | 18% | 8% | -5% | -1% | -21% | -13% | 2% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Investor Presentation 49m
-
Outcome Of The Board Meeting In Compliance Of Regulation 30 And 33 Of The SEBI (LODR) Regulations, 2015
3h - Board approved Q2 FY26 results; DyStar SPA USD676.26m sale delayed; long-stop extended to Dec 1, 2025.
-
Board Meeting Outcome for Outcome Of The Board Meeting In Compliance Of Regulation 30 And 33 Of The SEBI (LODR) Regulations, 2015
3h - Board approved Q2/H1 FY26 results; DyStar SPA to sell 37.57% for USD 676.26m; long-stop extended to Dec 1, 2025.
-
Updates On Court Case
2d - SPA for 37.57% DyStar (USD 676.26m) extended to Dec 1, 2025; USD5.112m extra deposit.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
3 Nov - Schedule of Earnings Conference Call to discuss the Financial Performance of the Company for the quarter and half year ended on September 30, 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
-
Financial Year 2012
from bse
Concalls
-
Nov 2025TranscriptNotesPPT
-
Sep 2025Transcript PPT
-
Aug 2025TranscriptNotesPPT REC
-
Jun 2025Transcript PPT REC
-
Mar 2025Transcript PPT
-
Feb 2025TranscriptNotesPPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptNotesPPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Dec 2021TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
-
Jul 2021Transcript PPT
-
Feb 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Jun 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Feb 2019TranscriptNotesPPT
-
Dec 2018TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
Product Segments
1) Dye Intermediates (52% in H1 FY25 vs 63% in FY22): [1] [2] The company supplies intermediates such as H-acid, Vinyl Sulphone, Naphthalene, Aniline, etc to manufacturers of reactive dyes.